Liver steatosis is the medical term for fatty liver, a condition where excess fat builds up inside liver cells. It’s defined as fat occupying more than 5% of the liver’s tissue. Most people with it have no symptoms at all, and it’s typically discovered by accident when imaging is done for an unrelated reason.
The condition has become remarkably common, affecting roughly 1 in 4 adults worldwide. While fat in the liver sounds alarming, steatosis itself is considered the earliest and most reversible stage of liver disease. The key is understanding what drives it, how it’s detected, and when it becomes a concern.
How Fat Accumulates in the Liver
Your liver constantly processes fat. It pulls fatty acids from your bloodstream, manufactures new fat from sugars you eat, burns fat for energy, and packages fat into particles that get shipped out to the rest of your body. Steatosis develops when the balance tips: more fat coming in and being made than the liver can burn or export.
Four pathways control this balance. First, the liver absorbs circulating fats through specialized transport proteins on the surface of liver cells. Second, the liver converts excess sugars (especially fructose and glucose) into brand-new fat molecules through a process called de novo lipogenesis. Insulin and carbohydrates both ramp up this fat-manufacturing process, which is why insulin resistance and high-sugar diets are so closely linked to fatty liver.
On the other side of the equation, the liver burns fat for energy inside its mitochondria, the cell’s power plants. When fat intake overwhelms these energy factories, the backlog grows. The liver also exports fat by wrapping it in protein shells that travel through the bloodstream. Insulin actually suppresses this export system, so people with high insulin levels (common in obesity and type 2 diabetes) lose efficiency on both sides: they make more fat and ship less of it out.
Updated Naming: MASLD Replaces NAFLD
If you’ve seen the term “NAFLD” (non-alcoholic fatty liver disease), that name was officially retired in 2023. The condition is now called MASLD, which stands for metabolic dysfunction-associated steatotic liver disease. The change wasn’t just cosmetic. The old name defined the disease by what it wasn’t (not caused by alcohol), while the new name identifies what it is: fatty liver driven by metabolic problems.
A MASLD diagnosis requires hepatic steatosis plus at least one of five cardiometabolic risk factors, including conditions like elevated blood sugar, high blood pressure, excess waist circumference, abnormal cholesterol, or elevated triglycerides. A separate category, MetALD, now covers people who have these metabolic factors and also drink moderate to heavy amounts of alcohol (more than about 10 drinks per week for women or 15 for men).
Grades of Steatosis
Steatosis is graded by how much of the liver tissue is affected by fat:
- Mild (Grade 1): 5% to 33% of liver tissue contains fat
- Moderate (Grade 2): 34% to 66%
- Severe (Grade 3): more than 66%
These grades matter because higher fat content correlates with greater risk of inflammation and progression. But even mild steatosis signals that something metabolic is off and worth addressing.
Symptoms and How It’s Found
Most people feel nothing. When symptoms do appear, they tend to be vague: fatigue, general discomfort in the upper right side of the abdomen, or a sense of heaviness after eating. These overlap with dozens of other conditions, which is why steatosis is almost never diagnosed from symptoms alone.
Instead, it’s usually spotted incidentally. A routine blood test might show mildly elevated liver enzymes, prompting an ultrasound. Or an imaging scan for something completely unrelated, like gallstones or back pain, reveals a bright, echogenic liver characteristic of fat accumulation.
How Steatosis Is Measured
Ultrasound is the most common first-line tool. It can detect steatosis once fat content reaches roughly 20% to 30%, but it can’t precisely quantify how much fat is present or assess scarring.
A FibroScan offers more detail. This device uses a specialized ultrasound technique that measures both liver stiffness (a marker of scarring) and something called a CAP score, which quantifies fat. CAP scores between 238 and 260 dB/m correspond to mild steatosis (S1), scores of 260 to 290 dB/m indicate moderate steatosis (S2), and scores above 290 dB/m suggest severe steatosis (S3).
For the most precise measurement, MRI-based fat quantification (called MRI-PDFF) calculates the exact percentage of fat in liver tissue. It’s accurate, reproducible, and doesn’t depend on the operator’s skill. MRI-PDFF expresses fat content as a simple percentage from 0% to 100%, and both repeat scans and different readers produce nearly identical results. It’s increasingly used in clinical trials but also available in many hospital settings for patients who need precise monitoring.
When Steatosis Becomes Dangerous
Simple steatosis, fat without inflammation, carries a relatively low risk on its own. The real concern is progression. In some people, fat accumulation triggers chronic inflammation in the liver, a stage now called MASH (metabolic dysfunction-associated steatohepatitis, formerly NASH). Sustained inflammation leads to fibrosis, where scar tissue replaces healthy liver cells.
Not everyone progresses. But a significant minority does so quickly. A meta-analysis of patients who had two liver biopsies over time found that about 21% were “rapid progressors,” developing advanced fibrosis from minimal or no scarring over an average of roughly 6 years. That means about 1 in 5 people with fatty liver moved to a serious stage within a relatively short window. The rest progressed slowly or not at all.
The factors that increase progression risk are largely the same ones that caused the fat buildup in the first place: uncontrolled diabetes, obesity, continued high-sugar and high-fat diets, and physical inactivity. Genetics also play a role, with certain gene variants significantly raising the odds of inflammation and fibrosis.
Reversing Fatty Liver
The most effective treatment is weight loss, and the thresholds are well established. Losing 3% to 5% of your body weight is typically enough for fat to start clearing from liver cells. That’s about 6 to 10 pounds for someone who weighs 200 pounds. Losing 10% or more of body weight goes further, improving not just the fat but also the inflammation and early scarring that may have already developed.
The method of weight loss matters less than the result. A combination of dietary changes and regular exercise produces the most consistent improvements. Reducing sugar intake is particularly relevant because of how directly fructose and glucose drive fat production in the liver. Cutting back on sugary drinks alone can produce measurable drops in liver fat within weeks.
Exercise helps even without significant weight loss. Aerobic activity and resistance training both improve the liver’s ability to burn fat and reduce the inflammatory signals that drive progression. About 150 minutes per week of moderate activity is the general target supported by liver disease guidelines.
For people with more advanced disease, newer medications targeting the inflammatory and fibrotic pathways are now available, and the treatment landscape has expanded considerably in recent years. Bariatric surgery has also shown dramatic reductions in liver fat and fibrosis for patients with severe obesity who haven’t responded to lifestyle changes alone.
What Steatosis Means for Overall Health
Fatty liver isn’t just a liver problem. People with MASLD have a significantly higher risk of cardiovascular disease, and heart attacks and strokes are actually the leading cause of death in this population, not liver failure. The same metabolic dysfunction that fills liver cells with fat also damages blood vessels, raises blood pressure, and promotes dangerous cholesterol patterns.
Type 2 diabetes and fatty liver fuel each other in a cycle. Insulin resistance promotes fat storage in the liver, and a fatty liver worsens insulin resistance throughout the body. Breaking the cycle at any point, whether through weight loss, improved diet, or better blood sugar control, benefits both conditions simultaneously.